Scale -


  • Revenue is 2564 Rs Cr; Annual Growth is 22 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 16 %
  • Ebitda is 665 Rs Cr; Annual Growth is 40 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 31 %
  • PBT is 113 Rs Cr; Annual Growth is 73 %; in Top Quartile; 5 Year CAGR is 35 %
  • PAT is 317 Rs Cr; Annual Growth is 71 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 34 %
  • Quarterly Revenue is 666 Rs Cr; in Top Quartile

Profitability -


  • PBDIT Margin is 25.95 %; Annual Growth is 15 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 13 %
  • PAT Margin is 12.35 %; Annual Growth is 41 %; Continuous Growth over 3 years; 5 Year CAGR is 16 %
  • Quarterly Ebitda Margin is 23 %; in Top Quartile; Continuous Decline over 3 Quarters

Return -


  • ROCE is 25.11 %; Annual Growth is 24 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 20 %
  • ROA is 10.33 %; Annual Growth is 54 %; Continuous Growth over 3 years; 5 Year CAGR is 23 %
  • ROE is 23.18 %; Annual Growth is 37 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 18 %
  • Asset Turnover is 86 %; Continuous Growth over 3 years

Efficiency -


  • Quick Ratio is 0.7; Annual Growth is 35 %; in Bottom Quartile
  • Operating cash flow is 550 Rs Cr; Annual Growth is 96 %; in Top Quartile; 5 Year CAGR is 228 %
  • Inventory Turnover Ratio is 3.18; Continuous Growth over 3 years

Solvancy -


  • Debt/Equity is 0.72; Continuous Decline over 3 years; in Top Quartile
  • Contingent Liabilities is 171 Rs Cr; Annual Growth is 46 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 25 %
  • Long term Debt is 578 Rs Cr; Continuous Growth over 3 years; in Top Quartile
  • Total Debt is 1010 Rs Cr; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 83 %; Annual Growth is 39 %; in Top Quartile; 5 Year CAGR is 151 %
  • Change in Inventories/Total Expenses is -2 %; in Bottom Quartile
  • Operating cashflow/PAT is 174 %; 5 Year CAGR is 144 %
  • Current Tax/PAT is 39 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Privi Speciality Chemicals Q2 2027 Earnings Call Is Live
Privi Speciality Chemicals Q2 FY27 Results: Profits Rise, Expansion on Track
Privi Speciality Chemicals Q2 FY27 Results: Revenue, EBITDA, PAT
Privi Speciality Chemicals Q2FY27 Results: Net profit rises 25% YoY to ?117.03 crore
Privi Speciality Chemicals: Reports Strong Q2 FY27 Growth, Eyes 2x Expansion
PRIVISCL: Record Q2 results underpin 20% growth guidance, with expansion approvals key to delivery
Privi Speciality Chemicals (NSE:PRIVISCL) Q2 FY27: What Do Results and Dividend Plans Reveal?
Privi Speciality Chemicals (PRIVISCL) Share Price Falls 5.30% to Rs 3,290.70 Today
Privi Speciality Chemicals PRIVISCL Dividend & Q2 FY27 Results
Privi Speciality Chemicals Q2 Profit Rises 30%; Declares Rs 5 Dividend
Privi Speciality Chemicals Reports 8.7% Q2 Revenue Growth; PAT Rises 24.7% Year on Year
Privi Speciality Chemicals Reports Q2 Net Profit Of ?120 Crore On Revenue Of ?760 Crore
Privi Speciality Chemicals (NSE:PRIVISCL) Shareholders Back Amalgamation Scheme
Privi Speciality shareholders approve subsidiary amalgamation with 89.72% votes
13 chemical stocks: Motilal Oswal has Buy on SRF, Atul, Vinati, Galaxy; Sell on Deepak Nitrite, Fine Organic
Privi Speciality Chemicals (BSE:530117) Stock Forecast & Analyst Predictions
Privi Speciality Chemicals (PRIVISCL.NS) Holds Firm Near ?3,389 as Buyers Defend Higher Ground
Specialty chemical stocks rally as earnings hopes lift trading volumes
Privi Speciality Chemicals (PRIVISCL.NS) Holds Above ?3,500 as ?3,343 Support Comes Into Focus
Privi Speciality Chemicals (PRIVISCL.NS) Slips 1.97% to ?3449.8 as Stock Holds Above Key Support
Privi Speciality Chemicals wins NCLT go-ahead for subsidiary merger process